Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe Asthma
杜皮鲁玛
哮喘
哮喘恶化
医学
免疫学
作者
Ian Pavord,Thomas B. Casale,Jonathan Corren,Mark J. FitzGerald,Yamo Deniz,Arman Altincatal,Rebecca Gall,Nami Pandit‐Abid,Amr Radwan,Juby A. Jacob‐Nara,Paul J. Rowe,William W. Busse
Changes from baseline in fractional exhaled nitric oxide (FeNO) and blood eosinophil count (Eos) may be related to efficacy outcomes in dupilumab-treated patients with moderate-to-severe asthma.